ConMed CNMD
$46.56 +$0.18 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.56 0.00%
Open$46.11
Prev close$46.38
Day range$45.94 – $48.00
Volume384.3K
Market cap$1.39B
P/E (TTM)19.3
Dividend yield–
Earnings
Average move on report day±6.2%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+16.5%
Worst reaction-12.4%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | ±11.2% | -0.09% | Within range |
| 2026/Q2 | 29 Jul 2026 | After Market | ±8.1% | +8.72% | Bigger than priced |
| 2026/Q1 | 29 Apr 2026 | After Market | ±13.3% | +1.95% | Within range |
| 2025/Q4 | 28 Jan 2026 | After Market | ±11.4% | -3.57% | Within range |
| 2025/Q3 | 5 Nov 2025 | After Market | ±8.6% | -0.52% | Within range |
| 2025/Q2 | 30 Jul 2025 | After Market | ±10.6% | +2.01% | Within range |
| 2025/Q1 | 30 Apr 2025 | After Market | ±12.0% | +16.45% | Bigger than priced |
| 2024/Q4 | 5 Feb 2025 | After Market | ±11.4% | -8.97% | Within range |
| 2024/Q3 | 30 Oct 2024 | After Market | ±16.9% | +4.57% | Within range |
| 2024/Q2 | 31 Jul 2024 | After Market | ±12.0% | -5.36% | Within range |
| 2024/Q1 | 24 Apr 2024 | After Market | ±9.4% | -11.58% | Bigger than priced |
| 2023/Q4 | 31 Jan 2024 | After Market | ±9.1% | -12.38% | Bigger than priced |
| 2023/Q3 | 25 Oct 2023 | After Market | ±10.4% | +2.95% | Within range |
| 2023/Q2 | 26 Jul 2023 | After Market | ±9.8% | -3.60% | Within range |
| 2023/Q1 | 26 Apr 2023 | After Market | ±8.7% | +12.33% | Bigger than priced |
| 2022/Q4 | 2 Feb 2023 | After Market | ±10.1% | -4.34% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$335.56M-0.7% YoY
Operating profit$37.14M+212.7% YoY
Net profit$19.80M+592.4% YoY
Diluted EPS$0.66+633.3% YoY
Free cash flow$46.73M-3.7% YoY
Operating cash flow$49.41M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin57.6%
Operating margin9.9%
Net margin5.4%
Return on equity7.1%
Return on assets3.2%
Return on invested capital5.2%
Current ratio1.49
Liabilities / assets54.0%
Cash & investments$47.97M
Total debt$815.87M
Net cash (debt)-$767.89M
Free cash flow / sales9.7%
No comments yet — be the first to weigh in on CNMD.
Sign in to join the discussion.